Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech

Source: 
Harvard Business School

Date

2010

Case Study Sector

Management

In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to the integration of Aurora into Vertex were still unresolved, the most pressing being Aurora's major collaboration with the Cystic Fibrosis Foundation (CFF). Were venture philanthropy and foundation deals an appropriate funding mechanism for a public company like Vertex? How could the board of Vertex and the CFF fundamentally align the objectives of a for-profit company with those of a non-profit institution? Those were the questions faced by the Vertex executives.

Link

Keyword

  • Field Building
  • Strategy

Region

  • Northern America

Blog Posts

American Democracy: Time for Intensive Care

February 15, 2017

The head of the Hewlett Foundation provides a tour d’horizon of American political dysfunction — and envisions a long and difficult therapy to bring it back to health. 

Events

Oct 05

Rip Rapson
President and CEO
The Kresge Foundation